Acevaltrate is primarily used in pharmaceutical research due to its potential neuroprotective and sedative properties. It has been investigated for its role in modulating central nervous system activity, particularly in relation to anxiety and epilepsy. Studies suggest it may enhance the effects of gamma-aminobutyric acid (GABA), a key inhibitory neurotransmitter, contributing to its calming effect on neuronal excitability. This makes it a compound of interest in the development of treatments for neurological disorders. Additionally, acevaltrate has shown anti-inflammatory and antioxidant activities in preclinical models, supporting its evaluation in formulations aimed at reducing oxidative stress and inflammation in the brain. Its natural origin from valerian species also makes it relevant in the study of herbal medicines for sleep and anxiety disorders.